NO20073379L - Forsterker av effekten av adrenokortikoid, som omfatter arabisk gummi. - Google Patents
Forsterker av effekten av adrenokortikoid, som omfatter arabisk gummi.Info
- Publication number
- NO20073379L NO20073379L NO20073379A NO20073379A NO20073379L NO 20073379 L NO20073379 L NO 20073379L NO 20073379 A NO20073379 A NO 20073379A NO 20073379 A NO20073379 A NO 20073379A NO 20073379 L NO20073379 L NO 20073379L
- Authority
- NO
- Norway
- Prior art keywords
- adrenocorticoid
- effect
- amplifier
- arabic rubber
- includes arabic
- Prior art date
Links
- 230000000694 effects Effects 0.000 title abstract 5
- 201000008383 nephritis Diseases 0.000 abstract 2
- 244000215068 Acacia senegal Species 0.000 abstract 1
- 229920000084 Gum arabic Polymers 0.000 abstract 1
- 240000007472 Leucaena leucocephala Species 0.000 abstract 1
- 235000010489 acacia gum Nutrition 0.000 abstract 1
- 239000000205 acacia gum Substances 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 229940125697 hormonal agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004346673 | 2004-11-30 | ||
| PCT/JP2005/022267 WO2006059764A2 (fr) | 2004-11-30 | 2005-11-29 | Amplificateur de l'effet d'un adrenocorticoide, contenant de la gomme arabique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20073379L true NO20073379L (no) | 2007-06-29 |
Family
ID=36250826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20073379A NO20073379L (no) | 2004-11-30 | 2007-06-29 | Forsterker av effekten av adrenokortikoid, som omfatter arabisk gummi. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20090060944A1 (fr) |
| EP (1) | EP1817040A2 (fr) |
| JP (1) | JP2008521791A (fr) |
| KR (1) | KR20070084588A (fr) |
| CN (1) | CN101232889A (fr) |
| AP (1) | AP2007004022A0 (fr) |
| AU (1) | AU2005310453A1 (fr) |
| BR (1) | BRPI0518712A2 (fr) |
| CA (1) | CA2584136A1 (fr) |
| IL (1) | IL182951A0 (fr) |
| MA (1) | MA29105B1 (fr) |
| MX (1) | MX2007006365A (fr) |
| NO (1) | NO20073379L (fr) |
| RU (1) | RU2007124549A (fr) |
| TW (1) | TW200631590A (fr) |
| WO (1) | WO2006059764A2 (fr) |
| ZA (1) | ZA200704404B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200803883A (en) * | 2005-09-22 | 2008-01-16 | Veritron Ltd | Enhancer of cholinesterase activity |
| DE102006061517A1 (de) * | 2006-12-18 | 2008-06-19 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Angioinhibin |
| DE102007039310A1 (de) * | 2007-08-13 | 2009-02-19 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Zusammensetzung zur Prophylaxe und Behandlung von Osteoporose |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB841998A (en) * | 1956-11-28 | 1960-07-20 | Merck & Co Inc | Steroid compounds |
| US5554386A (en) * | 1986-07-03 | 1996-09-10 | Advanced Magnetics, Inc. | Delivery of therapeutic agents to receptors using polysaccharides |
-
2005
- 2005-11-29 BR BRPI0518712-5A patent/BRPI0518712A2/pt not_active IP Right Cessation
- 2005-11-29 CA CA002584136A patent/CA2584136A1/fr not_active Abandoned
- 2005-11-29 JP JP2007542226A patent/JP2008521791A/ja not_active Withdrawn
- 2005-11-29 CN CNA2005800410645A patent/CN101232889A/zh active Pending
- 2005-11-29 WO PCT/JP2005/022267 patent/WO2006059764A2/fr not_active Ceased
- 2005-11-29 AP AP2007004022A patent/AP2007004022A0/xx unknown
- 2005-11-29 MX MX2007006365A patent/MX2007006365A/es not_active Application Discontinuation
- 2005-11-29 RU RU2007124549/15A patent/RU2007124549A/ru not_active Application Discontinuation
- 2005-11-29 KR KR1020077011945A patent/KR20070084588A/ko not_active Withdrawn
- 2005-11-29 EP EP05811246A patent/EP1817040A2/fr not_active Withdrawn
- 2005-11-29 US US11/667,690 patent/US20090060944A1/en not_active Abandoned
- 2005-11-29 AU AU2005310453A patent/AU2005310453A1/en not_active Abandoned
- 2005-11-30 TW TW094142202A patent/TW200631590A/zh unknown
-
2007
- 2007-05-03 IL IL182951A patent/IL182951A0/en unknown
- 2007-05-29 ZA ZA200704404A patent/ZA200704404B/en unknown
- 2007-06-18 MA MA30018A patent/MA29105B1/fr unknown
- 2007-06-29 NO NO20073379A patent/NO20073379L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20090060944A1 (en) | 2009-03-05 |
| TW200631590A (en) | 2006-09-16 |
| MX2007006365A (es) | 2007-06-20 |
| IL182951A0 (en) | 2007-09-20 |
| KR20070084588A (ko) | 2007-08-24 |
| MA29105B1 (fr) | 2007-12-03 |
| WO2006059764A3 (fr) | 2007-04-19 |
| BRPI0518712A2 (pt) | 2008-12-02 |
| AU2005310453A1 (en) | 2006-06-08 |
| ZA200704404B (en) | 2008-08-27 |
| EP1817040A2 (fr) | 2007-08-15 |
| WO2006059764A2 (fr) | 2006-06-08 |
| CN101232889A (zh) | 2008-07-30 |
| AP2007004022A0 (en) | 2007-06-30 |
| CA2584136A1 (fr) | 2006-06-08 |
| RU2007124549A (ru) | 2009-01-10 |
| JP2008521791A (ja) | 2008-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4357783A3 (fr) | Système et procédés hautement sensibles pour l'analyse de troponine | |
| EA200701918A1 (ru) | Белок липокалин | |
| WO2006119295A3 (fr) | Compositions et methodes de traitement de maladies neurodegeneratives | |
| EP1963530A4 (fr) | Polymérases actives couplées à des surfaces | |
| ATE496933T1 (de) | Reines rocuroniumbromid | |
| CY1115745T1 (el) | Συνθεσεις και μεθοδοι για αντιμετωπιση ή προληψη σχετιζομενης με οξαλικα νοσου | |
| EA201100908A1 (ru) | Расширенные растворимые полипептиды рн20 и их использование | |
| NO20075145L (no) | Farmakokinetisk forbedrede forbindelser | |
| NO20076401L (no) | Diarylhydantoinforbindelser | |
| NO20070876L (no) | Apolipoprotein A1 mimetics og anvendelser derav. | |
| WO2009029550A3 (fr) | Système ultra-sensible et procédés d'analyse d'antigène spécifique de la prostate (psa) | |
| DK1877390T3 (da) | Benzisoxazol-piperazin-forbindelser og fremgangsmåder til anvendelse deraf | |
| WO2007021672A3 (fr) | Vaccination contre l'infection par le virus de la dengue | |
| WO2007016591A3 (fr) | Compositions et methodes destinees a surveiller et modifier le repliement et la solubilite proteiques | |
| NO20082345L (no) | Selektive VPAC2 reseptorpeptidagonister | |
| WO2007047408A3 (fr) | Application de signature promac | |
| WO2006031926A3 (fr) | Procedes d'isolation et d'expansion de lymphocytes t regulateurs derives du sang du cordon ombilical | |
| MX2007008723A (es) | Polipeptidos de yersinia spp y metodos de uso. | |
| NO20073379L (no) | Forsterker av effekten av adrenokortikoid, som omfatter arabisk gummi. | |
| WO2009082445A3 (fr) | Nouveaux dispositifs pour la détection de la présence et/ou de l'activité de protéases dans des échantillons biologiques | |
| ATE549638T1 (de) | 13c-mr-bildgebung oder spektroskopie von zelltod | |
| WO2007010379A3 (fr) | Evaluation calorimetrique de micro-organismes et utilisation | |
| ATE429011T1 (de) | Bandbreitenerweiterung eines schmalbandigen akustischen signals | |
| WO2009048658A3 (fr) | Peptide optimisé (dn81), inhibiteur d'infiltration du virus de la dengue | |
| NO20080037L (no) | Kombinasjon av pyrimidylaminobenzamidforbindelser og imatinib for behandling eller forbyggelse av proliferative sykdommer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |